BioHealth News Archive
RegenxBio expanding to new Rockville HQ – Washington Business Journal
Rockville-based RegenxBio Inc. is on the move — to a site about 300 yards from its current home. {iframe}https://www.bizjournals.com/washington/news/2018/11/07/this-rockville-biotech-is-expanding-to-a-new-hq.amp.html{/iframe}
Read More
Lilly, NextCure Launch Cancer Immunotherapy Partnership | GEN – Genetic Engineering and Biotechnology News
Eli Lilly will use NextCure’s Functional, Integrated, NextCure Discovery in Immuno Oncology (FIND-IO™) platform to discover and develop cancer targets for new immuno-oncology therapies,…
Read More
Baltimore’s ETC (Emerging Technology Center) Announces Eighth Year of AccelerateBaltimore
ETC (Emerging Technology Center), Baltimore City's award-winning technology and innovation center, announced today that its AccelerateBaltimore program will run for its eighth consecutive year,…
Read More
Intersection between big data and therapeutic pipeline in neuromuscular disease will be life-changing for 250,000 patients and caregivers | Muscular Dystrophy Association
A new report funded by the Muscular Dystrophy Association (MDA) and released by the IQVIA Institute for Human Data Science indicates that genetic testing…
Read More
Leonard Freedman Named Chief Science Officer of Leidos-Operated Frederick National Laboratory | ExecutiveBiz
Leonard Freedman, founding president of the Global Biological Standards Institute, has been appointed chief science officer at a federally funded research and development center…
Read More
Top 25 Biotech Companies of 2018
While several biopharma giants (including Amgen, Novartis, and Merck & Co.) reported third-quarter earnings that beat expectations in recent days, biotechs appear to have…
Read More
2018’s Fiercest Women in Life Sciences – FiercePharma
Things are looking up for women—or so they seem. In the era of #MeToo, more and more women are speaking up about workplace harassment…
Read More
Getting Paid for Your BioHealth Innovation – Reimbursement Planning (11/14)
How do you obtain coverage and payment for your technology? Is the process different for medical devices from diagnostics or therapeutics? Can digital apps…
Read More
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIH SBIR Omnibus Solicitations
A ‘Direct-to-Phase II’ SBIR award is a Phase II award issued to a small business that did not receive a Phase I award for…
Read More
Thermo Fisher Scientific opens new biorepository in Maryland, US – Pharma Business review
Thermo Fisher Scientific, a biotech product development company, has inaugurated a new business center and biorepository in Frederick, located in the US state of…
Read More
Southern Research completes $13 million renovation of Frederick facility – Southern Research
Southern Research marked the completion of a $13 million renovation project at its Frederick Infectious Disease Research Center with a ribbon-cutting ceremony today attended…
Read More
Indivumed opens US-Headquarter in Frederick, MD: Indivumed
With a symposium about „Personalized Medicine Depends on Tissue Quality“ and an opening ceremony in presence of Benjamin Wu, Maryland Deputy Secretary of Commerce,…
Read More
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in…
Read More
Wound Care Advantage taps Tissue Analytics for AI, smartphone offering | MobiHealthNews
Sierra Madre, California-based Wound Care Advantage, a manager of outpatient wound treatment centers, has partnered with Baltimore-based Tissue Analytics to use the digital health…
Read More
How the Biopharmaceutical Industry Contributes to Open Scientific Knowledge – ITIF
Price controls under consideration by the administration would reduce the biopharmaceutical industry’s investment in R&D, which would slow the pace of drug discovery. It…
Read More